BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15037192)

  • 1. Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA.
    Mischiati C; Finotti A; Sereni A; Boschetti S; Baraldi PG; Romagnoli R; Feriotto G; Jeang KT; Bianchi N; Borgatti M; Gambari R
    Biochem Pharmacol; 2004 Feb; 67(3):401-10. PubMed ID: 15037192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1, 4]benzodiazepine and minor-groove-binding oligopyrrole carriers.
    Baraldi PG; Balboni G; Cacciari B; Guiotto A; Manfredini S; Romagnoli R; Spalluto G; Thurston DE; Howard PW; Bianchi N; Rutigliano C; Mischiati C; Gambari R
    J Med Chem; 1999 Dec; 42(25):5131-41. PubMed ID: 10602698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Leoni A; Bianchi N; Feriotto G; Rutigliano C; Mischiati C; Gambari R
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1219-29. PubMed ID: 11097052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid.
    Baraldi PG; Cacciari B; Guiotto A; Leoni A; Romagnoli R; Spalluto G; Mongelli N; Howard PW; Thurston DE; Bianchi N; Gambari R
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3019-24. PubMed ID: 9873668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site.
    Mischiati C; Borgatti M; Feriotto G; Rutigliano C; Breda L; Bianchi N; Gambari R
    Int J Mol Med; 2002 Jun; 9(6):633-9. PubMed ID: 12011981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.
    Wang W; Guo Z; Chen Y; Liu T; Jiang L
    Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
    Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
    J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
    Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
    J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    He M; Yuan D; Lin W; Pang R; Yu X; Yang M
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3978-81. PubMed ID: 16039124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds.
    Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D
    Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
    Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
    Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.
    Kolb G; Reigadas S; Boiziau C; van Aerschot A; Arzumanov A; Gait MJ; Herdewijn P; Toulmé JJ
    Biochemistry; 2005 Mar; 44(8):2926-33. PubMed ID: 15723535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors.
    Pang R; Zhang C; Yuan D; Yang M
    Bioorg Med Chem; 2008 Sep; 16(17):8178-86. PubMed ID: 18693018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro cytotoxic studies of novel bis-pyrrolo[2,1][1,4] benzodiazepine-pyrrole and imidazole polyamide conjugates.
    Kumar R; Lown JW
    Eur J Med Chem; 2005 Jul; 40(7):641-54. PubMed ID: 15935899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.